Skip to main content

Lactoferricin Antiangiogenesis Inhibitor

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 48 Accesses

Definition

Lactoferricin is a cationic peptide that is generated by the acid-pepsin hydrolysis of mammalian lactoferrin present in the secretory granules of neutrophils (polymorphonuclear leukocytes) as well as in exocrine secretions, including milk, tears, and saliva. Interestingly, substantial quantities of lactoferricin are generated in the stomach following the ingestion of lactoferrin-containing milk. Lactoferricin possesses potent antimicrobial, antiviral, immunomodulatory, and antitumor activities. In terms of anticancer activity, the best studied of the lactoferricins is bovine lactoferricin, which consists of amino acid residues 17–41 from the NH2-terminal region of bovine lactoferrin (Fig. 1). A disulfide bond that forms between cysteine residues located at each end of the peptide creates a looped or hairpin structure. In an aqueous environment, bovine lactoferricin assumes an amphipathic, twisted β-sheet configuration with clear positively charged and hydrophobic faces. The...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Gifford JL, Hunter HN, Vogel HJ (2005) Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 62:2588–2598

    Article  CAS  PubMed  Google Scholar 

  • Mader JS, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15:933–946

    Article  CAS  PubMed  Google Scholar 

  • Mader JS, Smyth D, Marshall JS et al (2006) Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis by competing for heparin-like binding sites on endothelial cells. Am J Pathol 169:1753–1766

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vogel HJ, Schibli DJ, Jing W et al (2002) Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem Cell Biol 80:49–63

    Article  CAS  PubMed  Google Scholar 

  • Yoo Y-C, Watanabe S, Watanabe R et al (1997) Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88:184–190

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David W. Hoskin .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Hoskin, D.W. (2015). Lactoferricin Antiangiogenesis Inhibitor. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_3261-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_3261-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics